How Quickly Does Cosentyx Start Working?
Cosentyx (secukinumab), an IL-17A inhibitor for psoriasis, psoriatic arthritis, ankylosing spondylitis, and other inflammatory conditions, shows initial effects within 1-2 weeks for many patients. Visible skin improvements in psoriasis often appear by week 2, with 50-70% skin clearance (PASI 75) by week 12 in clinical trials.[1][2]
Loading doses—typically 300 mg weekly for the first 5 weeks—accelerate onset compared to standard 300 mg every 4 weeks.[3]
Onset by Condition
Psoriasis: Itch relief and plaque reduction start in 2-4 weeks; major clearance by 12 weeks. In the SCULPTURE trial, 82% achieved PASI 75 by week 12 with loading doses.[1]
Psoriatic Arthritis: Joint pain and swelling improve within 1-2 weeks; ACR20 response (20% improvement) hits 50% by week 4.[2]
Ankylosing S spondylitis: Back pain eases in 1-2 weeks; ASAS20 response reaches 60% by week 16.[2]
Individual response varies based on disease severity, body weight, and adherence.
Factors Affecting Speed
Higher doses (300 mg vs. 150 mg) and subcutaneous self-injection speed results. Obesity or prior biologic failure can delay onset. Full effects may take 3-6 months.[3]
What If It Doesn't Work Fast Enough?
About 20-30% of patients see minimal improvement by week 12; switching biologics or adding therapies like methotrexate is common. Monitor with dermatologist visits at weeks 4 and 12.[3]
Common Early Side Effects
Upper respiratory infections (10-15%) and injection-site reactions occur in the first weeks but rarely stop treatment.[2]
[1]: Novartis Cosentyx Prescribing Information
[2]: FDA Approval Summary for Secukinumab
[3]: DrugPatentWatch.com - Cosentyx Patents and Exclusivity